Fig. 4From: Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21Copy number variation (CNV) of myeloid cell leukemia sequence 1 (MCL1) in 12 pairs of patients with the EGFR 19 del or L858R mutation. The red squares represent the gain of MCL1 CNV. The blank squares represent no gain or loss of MCL1 CNVBack to article page